Results 191 to 195 of about 168,314 (195)

Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity. [PDF]

Front Immunol
Liu W, Zhang Y, Wei Y, Hu Y, Zhang X, Xue J, Li P.   +6 more
europepmc   +1 more source

Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies. [PDF]

Cancer Drug Resist
Chen Y, Ye Z, Wang Y, Liang S, Zhang DX.
europepmc   +1 more source

Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting. [PDF]

J Hepatocell Carcinoma
Su Y, Liang Y, Zhong D, Chen Y, Ma SS, Huang X.   +5 more
europepmc   +1 more source

Membrane-modified mesoporous silica nanoparticles guided by tumor immunomodulatory regulation for anti-tumor strategies. [PDF]

Front Immunol
Gao Y, Wu H, Liu T, Pu X, Ren T, An C, Zhang H, Yang J.   +7 more
europepmc   +1 more source

STJCE 12-12-2002, Lankhorst-Hohorst versus Finanzamt Steinfurt, As. C-324/00. Libertad de establecimiento; normas tributarias sobre subcapitalización; distribución encubierta de beneficios; coherencia del régimen fiscal; evasión fiscal

Crónica Tributaria, 2005
Manuel Lucas Durán
doaj